BioLineRx Ltd.
Alış

Mean reversion for BLRX

179
BLRX dumped over 40% yesterday on dilution news, an overreaction from the market imo. Bought the bottom around $0.15 which is way undervalued for what the company has in the pipeline. Company is now cash healthy for a while with $10 million for research. It's trading at $1,49 on the TASE - so heavy arbitrage opportunity for market makers here. Next to that, it has a buy rating and target for 9.00/share - that was pre-dilution, so you know what, let's cut that in half to $4.50 - works for me too.

Buying the blood and targeting a 100 to 500% move for mean reversion.

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.